Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/8/2019
SIETES contiene 92794 citas

 
 
 1 a 20 de 184 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
McQuaid J. Asthma takes a hard toll on African-Americans. Can precision medicine ease the burden?. STAT Daily Recap 2019:26 de marzo. [Ref.ID 103064]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page II RL, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2019;39:enero. [Ref.ID 103011]
3. Cita con resumen
Loftfield E, Cornelis MC, Caporaso N, Yu K, Sinha R, Freedman N. Association of coffee drinking with mortality by genetic variation in caffeine metabolism: findings from the UK biobank.. JAMA Intern Med 2018;178:1086-97. [Ref.ID 102776]
4.Enlace a cita original Cita con resumen
Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer Jr CE, Dees EC, Goetz MP, Olson Jr JA, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MC, Paik S, Wood WC, Ravdin PM, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Tppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge Jr GW. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med 2018;379:111-21. [Ref.ID 102694]
5. Cita con resumen
Greene JA, Loscalzo J. Putting the patient back together — Social medicine, network medicine, and the limits of reductionism. N Engl J Med 2017;377:2493-9. [Ref.ID 102185]
6. Cita con resumen
Trubiano JA, Adkinson NF, Phillips EJ. Penicillin allergy Is not necessarily forever. JAMA 2017;318:82-3. [Ref.ID 102053]
7. Cita con resumen
Nembhard WN, Tang X, Hu Z, MacLeod S, Stowe Z, Webber D, the National Birth Defects Prevention Study. Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study. BMJ 2017;356:j832. [Ref.ID 101588]
8. Cita con resumen
Anónimo. EMA advisory committee conditionally approves venetoclax. DIA Daily 2016:3. [Ref.ID 100811]
9. Cita con resumen
Wang Y, Zhao X, Lin J, Johnston C, Lin Y, Pan Y, Liu L, Wang D, Wang C, Meng X, Xu J, for the CHANCE Investigators. Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 2016;316:70-8. [Ref.ID 100516]
10. Cita con resumen
Anónimo. FDA approves lung cancer drug. DIA Daily 2015:16 de noviembre. [Ref.ID 99643]
11. Cita con resumen
Anónimo. FDA approves targeted therapy for first-line treatment of patients with a type of metastatic lung cancer. U.S. Food and Drug Administration 2015:13 de julio. [Ref.ID 99504]
12. Cita con resumen
Anónimo. New cancer research highlights shift In drug development. DIA Daily 2015:2 de junio. [Ref.ID 99121]
13. Cita con resumen
Hampton T. New drug delivery technologies may advance personalized cancer therapy. JAMA 2015;313:2114. [Ref.ID 99118]
14. Cita con resumen
Preiss D, Sattar N. Does the LDL receptor play a role in the risk of developing type 2 diabetes?. JAMA 2015;313:1016-7. [Ref.ID 98938]
15.Tiene citas relacionadas Cita con resumen
Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JEL, Shah T, Sofat R, Stender S, Johnson PCD, Scott RA, Leusink M, Verweij N, Sharp SJ, Guo Y, Giambartolomei C, Chung C, Peasey A, Amuzu A, Li K, Palmen J, Howard P, Cooper JA, Drenos F, Li YR, Lowe G, Gallacher J, Stewart MCW, Tzoulaki I, Buxbaum SG, van der A DL, Forouhi NG, Onland-Moret C, Van der Schouw YT, Schnabel RB, Hubacek JA, Kubinova R, Baceviciene M, Tamosiunas A, Pajak A, Topor-Madry R, Stepaniak U, Malyutina S, Baldassarre D, Sennblad B, Tremoli E, De Faire U, Veglia F, Ford I, Jukema JW, Westendorp RGJ, de Borst GJ, De Jong PA, Algra A, Spiering W, Maitland-van der Zee AH, Klungel OH, de Boer A, Doevendans PA, Eaton CB, Robinson JG, Duggan D, DIAGRAM Consortium, MAGIC Consortium, InterAct Consortium, Kjekshus J, Downs JR, Gotto AM, Keech AC, Marchioli R, Tognoni G, Sever PS, Poulter NR, Waters DD, Pedersen TR, Amarenco P, Nakamura H, McMurray JJV, Lewsley JD, Chasman D, Ridker PM, Magglioni AP, Tavazzi L, Ray KK, Seshasai SRK, Manson JE, Price JF, Whincup PH, Morris RW, Lawlor DA, Smith GD, Ben-Shlomo Y, Schreiner PJ, Forhage M, Siscovick DS, Cushman M, Kumari M, Wareham NJ, Verschuren WMM, Redline S, Patel SR, Whittaker JC, Hamsten A, Delaney JA, Dale C, Gaunt TR, Wong A, Kuh D, Hardy R, Kathiresan S, Castillo BA, van der Harst P, Brunner EJ, Tybjaerg-Hoogeveen A, Psaty BM, Lange LA, Hakonarson H, Dudbridge F, Humphries SE, Talmud PJ, Kivimäki M, Timpson NJ, Langenberg C, Asselbergs FW, Voevoda M, Bobak M, Pikhart H, Wilson JG, Reiner AP, Keating BJ, Hingorani AD, Sattar N. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet 2015;385:351-61. [Ref.ID 98804]
16.Tiene citas relacionadas Cita con resumen
Frayling TM. Statins and type 2 diabetes: genetic studies on target. Lancet 2015;385:310-2. [Ref.ID 98803]
17. Cita con resumen
Torjesen I. Personalised medicine trial in lung cancer heralds new partnership. BMJ 2014;348:g2837. [Ref.ID 97965]
18. Cita con resumen
Chung W-H, Chang W-C, Lee Y-S, Wu Y-Y, Yang -CH, Ho H-C, Chen MJ, Lin JY, Hui C-Y, Ho J-C, Wu W-M, Chen T-J, Wu T, Wu Y-R, Hsih M-S, Tu P-H, Chang C-N, Hsu C-N, Wu T-L, Choon S-E, Hsu C-K, Chen D-Y, Liu C-S, Lin C-Y, Kaniwa N, Saito Y, Takahashi Y, Nakamura R, Azukizawa H, Shi Y, Wang T-H, Chuang S-S, Tsai S-F, Chang C-J, Chang YS, Hung S-I, for the Taiwan Severe Cutaneous Adverse Reaction Consortium and the Japan Pharmacogenomics Data Science Consortium. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA 2014;312:525-34. [Ref.ID 97851]
20.Tiene citas relacionadas Cita con resumen
Furie B. Do pharmacogenetics have a role in the dosing of vitamin K antagonists?. N Engl J Med 2013;369:2345-6. [Ref.ID 96668]
Seleccionar todas
 
 1 a 20 de 184 siguiente >>